4D Molecular Therapeutics Chief Legal Officer Scott Bizily reports sale of $20,993.40 in common shares
FDMT•Chief Legal Officer Scott Bizily sold 1,635 shares at $12.84 each on Oct. 16, 2026, after exercising options for the same number of shares at $4.14 each. He directly owned 8,617 shares and held 56,431 options after the transactions.
1. Bizily’s share transactions
4D Molecular Therapeutics Chief Legal Officer Scott Bizily sold 1,635 common shares at $12.84 each on Oct. 16, 2026, and exercised options for 1,635 common shares at $4.14 each that day. Afterward, he directly owned 8,617 common shares and held 56,431 stock options.
